Erleada

Bayer sues J&J over 'deeply flawed' Erleada promotional claims

Bayer has filed a false advertising lawsuit taking issue with claims made by Johnson & Johnson to pit their prostate cancer drugs against one another.

Andrea Park Feb 23, 2026 1:03pm

J&J's Erleada shows survival edge over Xtandi in real-world study

Oct 2, 2024 2:42pm

J&J touts progress on new launches as Stelara cliff nears

Oct 17, 2023 10:15am

J&J breaks out the blue jacket for prostate cancer awareness

Feb 7, 2023 7:35am

J&J kicks off prostate cancer health disparities campaign

Sep 21, 2022 9:25am

Bayer's Nubeqa nabbed a second prostate cancer indication

Aug 8, 2022 10:13am